📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: GenePOC

1.1 - Company Overview

GenePOC Logo

GenePOC

Headquarter: Canada
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of accurate, cost-effective molecular solutions to detect pathogen genes, featuring a simple, stand-alone system for prevention and early detection of infectious diseases based on unique microfluidic technology; a privately owned member of Debiopharm Group.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to GenePOC

UrSure Logo

UrSure

HQ: United States Website
  • Description: Provider of patient-friendly diagnostic tests that measure and improve adherence to medications, initially focused on drugs that prevent and treat HIV.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full UrSure company profile →
CPTx Logo

CPTx

HQ: Germany Website
  • Description: Provider of programmable, single-stranded DNA-based therapeutics and platforms, including composite programmable therapeutics, antiviral countermeasures and a pipeline of antiviral drugs, programmable DNA nanofabrication, and a non-viral gene delivery platform; enabling precise control of drug presentation to target viruses (including influenza), cancer, and autoimmune disorders.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full CPTx company profile →
Alphyn Biologics Logo

Alphyn Biologics

HQ: United States Website
  • Description: Provider of proprietary drug therapies for skin diseases, including Zabalafin hydrogel (AB-101a), a steroid-free topical for atopic dermatitis targeting immune and bacterial components; the Zabalafin (AB-101) multi-bioactive platform; and AB-101b in development for Epidermolysis Bullosa to address inflammation, itch, pain, and skin infection.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Alphyn Biologics company profile →
NanoCures Logo

NanoCures

HQ: United States Website
  • Description: Provider of clinical-stage biotechnology and infectious disease immunity platforms, including: Cures Platform targeting specific genomic and molecular pathways to yield multiple therapeutics; Data/AI Platform using biometric, genomic, molecular, and environmental data with AI/ML to detect diseases early and guide new cure development; and Developer Platform offering resources, data, and tools to lower barriers and encourage innovation.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full NanoCures company profile →
Enantigen Logo

Enantigen

HQ: United States Website
  • Description: Provider of discovery, development, and commercialization of novel drugs for life-threatening infectious diseases, with a primary focus on oral therapeutics for the treatment of hepatitis; located at the Pennsylvania Biotechnology Center.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Enantigen company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for GenePOC

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to GenePOC

2.2 - Growth funds investing in similar companies to GenePOC

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for GenePOC

4.2 - Public trading comparable groups for GenePOC

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to GenePOC

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About GenePOC

What does GenePOC do?

GenePOC is a provider of accurate, cost-effective molecular solutions to detect pathogen genes, featuring a simple, stand-alone system for prevention and early detection of infectious diseases based on unique microfluidic technology; a privately owned member of Debiopharm Group.

Who are GenePOC's competitors?

GenePOC's competitors and similar companies include UrSure, CPTx, Alphyn Biologics, NanoCures, and Enantigen.

Where is GenePOC headquartered?

GenePOC is headquartered in Canada.

How many employees does GenePOC have?

GenePOC has 1,000 employees 🔒.

When was GenePOC founded?

GenePOC was founded in 2010 🔒.

What sector and industry vertical is GenePOC in?

GenePOC is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for GenePOC

Who are the top strategic acquirers in GenePOC's sector and industry

Top strategic M&A buyers and acquirers in GenePOC's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for GenePOC?

Top strategic M&A buyers groups and sectors for GenePOC include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in GenePOC's sector and industry vertical

Which are the top PE firms investing in GenePOC's sector and industry vertical?

Top PE firms investing in GenePOC's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in GenePOC's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in GenePOC's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in GenePOC's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to GenePOC include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in GenePOC's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for GenePOC?

The key public trading comparables and valuation benchmarks for GenePOC include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for GenePOC for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for GenePOC with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in GenePOC's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for GenePOC with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in GenePOC's' sector and industry vertical?

Access recent funding rounds and capital raises in GenePOC's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for GenePOC